v3.25.2
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities    
Net loss from continuing operations $ (14,071) $ (15,481)
Adjustments to reconcile net loss to net cash provided by operating activities    
Accretion expense 4,306 7,862
Depreciation of property and equipment and amortization of intangible assets 7,729 7,576
Amortization of operating right-of-use assets 805 777
Share-based compensation 2,293 3,445
Deferred income tax expense (recovery) 597 (415)
Gain on fair value of derivative liabilities (376) (1,939)
Unrealized and realized loss on investments 735 227
Loss from revaluation of contingent consideration 346 3,220
Provision for expected credit loss 673  
Unrealized and realized foreign exchange (gain) loss (607) 389
Impairment and other (5) 1,269
Changes in operating assets and liabilities    
Receivables (511) 1,517
Inventory 4,580 1,400
Accounts payable and accrued liabilities (5,046) (4,289)
Income taxes paid and tax related liabilities 16,862 25,238
Prepaid expense and other current assets 79 (52)
Other assets and liabilities 90 2,572
Net cash provided by operating activities - continuing operations 18,479 33,316
Net cash used in operating activities - discontinued operations (7,658) (7,177)
Net cash provided by operating activities 10,821 26,139
Investing activities    
Investment in property and equipment (4,650) (4,094)
Interest received on investment in note receivable 123  
Investment in intangible assets (726) (699)
Cash portion of consideration paid in acquisitions, net of cash acquired (5,128) (250)
Net cash used in investing activities - continuing operations (10,381) (5,043)
Net cash (used in) provided by investing activities - discontinued operations (737) 200
Net cash used in investing activities (11,118) (4,843)
Financing activities    
Proceeds from loan payable, net of transaction costs 5,000 3,137
Loan principal paid (1,966) (16,306)
Capital distributions paid to non-controlling interests (1,988) (1,564)
Payment for contingent consideration (386)  
Payments made for financing obligations and finance lease   (271)
Repurchases of common shares (377)  
Net cash provided by (used in) financing activities- continuing operations 283 (15,004)
Net cash used in financing activities- discontinued operations   (1,538)
Net cash provided by (used in) financing activities 283 (16,542)
Net increase in cash and cash equivalents and restricted cash during the period (14) 4,754
Net effects of foreign exchange (191) 390
Cash and cash equivalents and restricted cash, beginning of the period 26,987 25,347
Cash and cash equivalents and restricted cash, end of the period 26,782 30,491
Supplemental disclosure with respect to cash flows    
Cash paid (received) for income tax, net 4,573 (8,116)
Interest paid 13,266 12,599
Lease termination fee paid   271
Non-cash transactions    
Equity and warrant liability issued for acquisitions and non-controlling interest   4,674
Distribution Payable to Non-controlling Interests   719
Change in accrued capital expenditures $ 2,115 $ 811

Source

10-Q PDF
XBRL